The Big Idea

The Bahamas | Slow rating trajectory

| October 4, 2024

This document is intended for institutional investors and is not subject to all of the independence and disclosure standards applicable to debt research reports prepared for retail investors. This material does not constitute research.

The impressive 14% total returns so far this year ranks the Bahamas as one of the top regional emerging markets performers. However, the country’s sovereign debt now likely moves to a slower phase of spread compression with total returns largely reflecting carry as yields normalize below 9%. This sovereign remains an attractive option with relatively low beta and high carry at a mature phase of outperformance among other high yielding alternatives.

S&P just recently confirmed a neutral outlook on the Bahamas ‘B+’ rating. The Bahamas has been stable in the ‘B+’ category since the post-Covid shock in 2021 and 2022. The economic team remains focused on shifting the nominal fiscal deficit to surplus. This is a slow trajectory not only for the gradual approach to fiscal surplus but also the gradual path to reducing the high debt ratios. The fiscal gradualism isn’t ideal and leaves the economy vulnerable to latent external shocks, especially without the anchor of an International Monetary Fund program.

There has been credible policy management. There is more transparency, effective financing and significant fiscal adjustment.  The transition from a 3.7%-of-GDP fiscal deficit in FY2022/23 to a deficit of 1.3% of GDP in FY2023/24 shows impressive improvement and the beginning of an important track record towards their target goal. Next is corporate tax reform. That would help the Bahamas get to a fiscal deficit of 0.5% of GDP in FY2024/25. There will have to be more effort to improving tax collection, focused on property taxes and reducing broader VAT evasion. The spending restraint in the fourth quarter of FY2023/24 should also represent permanent as opposed to temporary cutbacks and a stabilizing adjuster for reaching the fiscal target if revenues disappoint.

S&P assumes conservative projections for low trend GDP growth of 1.5% and no further improvement on the fiscal deficit at 1.3% of GDP. The potential for higher ratings depend on “sustained near-balanced financial results and improved economic prospects.” The outlook remains neutral; however, S&P did signal positive rating action specifically referencing “successful implementation of a corporate income tax and carbon credits, combined with improved state-owned enterprise (SOE) finances after effectively executing energy sector reforms.” There is room for optimism, especially on follow-through approval of a corporate income tax before year end. The guidance is for consistent progress on lowering the fiscal deficit, gross financing needs and vulnerability to shocks.

The transition toward ‘BB’ will require a more decisive shift towards the targeted 2%-of-GDP fiscal surplus.  There have been various revisions to the target trajectory with the 2%-of-GDP fiscal surplus pushed back to FY2025/26. The progress on higher tax collection and spending restraint validates current sub-9% yields, however, it’s difficult to expect any rating upgrades or ‘BB’ credit convergence until the final phase of fiscal adjustment. This is not a controversial statement with high level officials also confirming much work to do. The approval of the corporate tax reform should further strengthen the track record with further efforts necessary on meeting their goal target.

The Bahamas current sub-9% yields seem appropriate with the current trajectory of fiscal gradualism and a mature phase of credit spread compression heading into next year. This suggests a shift from the 14% EMUSTRUU total returns YTD closer to carry returns into next year. This remains still a favorable alternative for its lower beta, off-index status and wide margin compared to ‘BB’ credits. There are not many other high yielding alternatives in the region, aside from the distressed credits of Argentina and Ecuador.

Siobhan Morden
siobhan.morden@santander.us
1 (212) 692-2539

This material is intended only for institutional investors and does not carry all of the independence and disclosure standards of retail debt research reports. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.

This message, including any attachments or links contained herein, is subject to important disclaimers, conditions, and disclosures regarding Electronic Communications, which you can find at https://portfolio-strategy.apsec.com/sancap-disclaimers-and-disclosures.

Important Disclaimers

Copyright © 2025 Santander US Capital Markets LLC and its affiliates (“SCM”). All rights reserved. SCM is a member of FINRA and SIPC. This material is intended for limited distribution to institutions only and is not publicly available. Any unauthorized use or disclosure is prohibited.

In making this material available, SCM (i) is not providing any advice to the recipient, including, without limitation, any advice as to investment, legal, accounting, tax and financial matters, (ii) is not acting as an advisor or fiduciary in respect of the recipient, (iii) is not making any predictions or projections and (iv) intends that any recipient to which SCM has provided this material is an “institutional investor” (as defined under applicable law and regulation, including FINRA Rule 4512 and that this material will not be disseminated, in whole or part, to any third party by the recipient.

The author of this material is an economist, desk strategist or trader. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM or any of its affiliates may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.

This material (i) has been prepared for information purposes only and does not constitute a solicitation or an offer to buy or sell any securities, related investments or other financial instruments, (ii) is neither research, a “research report” as commonly understood under the securities laws and regulations promulgated thereunder nor the product of a research department, (iii) or parts thereof may have been obtained from various sources, the reliability of which has not been verified and cannot be guaranteed by SCM, (iv) should not be reproduced or disclosed to any other person, without SCM’s prior consent and (v) is not intended for distribution in any jurisdiction in which its distribution would be prohibited.

In connection with this material, SCM (i) makes no representation or warranties as to the appropriateness or reliance for use in any transaction or as to the permissibility or legality of any financial instrument in any jurisdiction, (ii) believes the information in this material to be reliable, has not independently verified such information and makes no representation, express or implied, with regard to the accuracy or completeness of such information, (iii) accepts no responsibility or liability as to any reliance placed, or investment decision made, on the basis of such information by the recipient and (iv) does not undertake, and disclaims any duty to undertake, to update or to revise the information contained in this material.

Unless otherwise stated, the views, opinions, forecasts, valuations, or estimates contained in this material are those solely of the author, as of the date of publication of this material, and are subject to change without notice. The recipient of this material should make an independent evaluation of this information and make such other investigations as the recipient considers necessary (including obtaining independent financial advice), before transacting in any financial market or instrument discussed in or related to this material.

Important disclaimers for clients in the EU and UK

This publication has been prepared by Trading Desk Strategists within the Sales and Trading functions of Santander US Capital Markets LLC (“SanCap”), the US registered broker-dealer of Santander Corporate & Investment Banking. This communication is distributed in the EEA by Banco Santander S.A., a credit institution registered in Spain and authorised and regulated by the Bank of Spain and the CNMV. Any EEA recipient of this communication that would like to affect any transaction in any security or issuer discussed herein should do so with Banco Santander S.A. or any of its affiliates (together “Santander”). This communication has been distributed in the UK by Banco Santander, S.A.’s London branch, authorised by the Bank of Spain and subject to regulatory oversight on certain matters by the Financial Conduct Authority (FCA) and the Prudential Regulation Authority (PRA).

The publication is intended for exclusive use for Professional Clients and Eligible Counterparties as defined by MiFID II and is not intended for use by retail customers or for any persons or entities in any jurisdictions or country where such distribution or use would be contrary to local law or regulation.

This material is not a product of Santander´s Research Team and does not constitute independent investment research. This is a marketing communication and may contain ¨investment recommendations¨ as defined by the Market Abuse Regulation 596/2014 ("MAR"). This publication has not been prepared in accordance with legal requirements designed to promote the independence of research and is not subject to any prohibition on dealing ahead of the dissemination of investment research. The author, date and time of the production of this publication are as indicated herein.

This publication does not constitute investment advice and may not be relied upon to form an investment decision, nor should it be construed as any offer to sell or issue or invitation to purchase, acquire or subscribe for any instruments referred herein. The publication has been prepared in good faith and based on information Santander considers reliable as of the date of publication, but Santander does not guarantee or represent, express or implied, that such information is accurate or complete. All estimates, forecasts and opinions are current as at the date of this publication and are subject to change without notice. Unless otherwise indicated, Santander does not intend to update this publication. The views and commentary in this publication may not be objective or independent of the interests of the Trading and Sales functions of Santander, who may be active participants in the markets, investments or strategies referred to herein and/or may receive compensation from investment banking and non-investment banking services from entities mentioned herein. Santander may trade as principal, make a market or hold positions in instruments (or related derivatives) and/or hold financial interest in entities discussed herein. Santander may provide market commentary or trading strategies to other clients or engage in transactions which may differ from views expressed herein. Santander may have acted upon the contents of this publication prior to you having received it.

This publication is intended for the exclusive use of the recipient and must not be reproduced, redistributed or transmitted, in whole or in part, without Santander’s consent. The recipient agrees to keep confidential at all times information contained herein.

The Library

Search Articles